Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Quanterix Corp chart...

About the Company

quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).

Exchange

NASDAQ

Website

quanterix.com

$122M

Total Revenue

401

Employees

$1B

Market Capitalization

-28.48

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $QTRX News

Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease

14d ago, source:

Quanterix Corporation (NASDAQ: QTRX), a leading provider of ultra-sensitive research products and high-definition diagnostics ...

Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag

12d ago, source: Zacks.com on MSN

Quanterix Corporation QTRX, a player in ultra-sensitive research products and diagnostics, achieved a significant milestone when the FDA granted a Breakthrough Device designation to its Simoa ...

Quanterix’s Growth Catalysts: FDA Breakthrough Designation and Alzheimer’s Diagnostic Potential

12d ago, source: Business Insider

Begin your TipRanks Premium journey today. Quanterix (QTRX) Company Description: Quanterix Corp. is a life sciences company, which develops ultra-sensitive digital immunoassay platform that advances ...

Quanterix Corporation (NASDAQ:QTRX) Just Released Its Annual Results And Analysts Are Updating Their Estimates

15d ago, source:

It's been a good week for Quanterix Corporation ( NASDAQ:QTRX ) shareholders, because the company has just released ...

Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023

18d ago, source:

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the fourth quarter and twelve months ...

CryoPort Q4 2023 Earnings Preview

on MSN ago, source:

CryoPort is set to announce their Q4 earnings results, with an estimated EPS of -$0.30 and a revenue estimate of $58.39M.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...